MMTV-PyMT (MMTV-PyVmT) females develop palpable mammary tumors which metastasize to the lung. Mean latency is 92 days of age. Male carriers develop mammary tumors with a later onset. These mice express the Polyoma Virus middle T antigen under the direction of the mouse mammary tumor virus promoter/enhancer and may be suitable for use in studies related to breast cancer and altering the tumor microenvironment.
Lesley Ellies, University of California, San Diego
The MMTV-PyVmT transgene has the mouse mammary tumor virus (MMTV) long terminal repeat upstream of a cDNA sequence encoding the Polyoma Virus middle T antigen (PyVmT). Transgenic mice are viable, but show loss of lactational ability due to activation of the estrogen responsive transgene during pregnancy leading to tumorigenesis. Female carriers develop palpable mammary tumors with a mean latency of 92 days of age, as compared with 53 days in FVB/N-Tg(MMTV-PyVT)634Mul/J mice (Stock No. 002374). Adenocarcinomas arise in virgin and breeder females and occasionally in males, which are well-differentiated, multifocal and eventually involve the entire mammary fat pad. Tumor-bearing females have reduced lung metastasis compared to the 80-90% incidence found in FVB/N-Tg(MMTV-PyVT)634Mul/J mice. Transgene expression is detected at high levels in male and female mammary glands. Lower levels are detected in salivary gland, seminal vesicles, ovaries, and lungs (believed to be the result of pulmonary metastases).
This strain may be used as a platform to alter the tumor microenvironment. On the FVB/N background, tumor burden and pulmonary metastases have been shown to be reduced after in vivo TMP195 treatment by inducing the recruitment and differentiation of highly phagocytic and stimulatory macrophages within tumors. TMP195 treatment combined with chemotherapy regimens or T-cell checkpoint blockade was shown to significantly enhance the durability of tumor reduction.
To derive the MMTV-PyVmT transgene, cDNA encoding the Polyoma Virus middle T antigen was inserted into the expression vector, pMMTV-SV40, resulting in a fusion gene of the PyVT oncogene and SV40 poly A and 3' processing signals, driven by the Mouse Mammary Tumor Virus (MMTV) LTR. Construct DNA was injected into the pronuclei of FVB/N zygotes. Transgenic progeny were identified by Southern blot analysis using a PyVT cDNA probe and founder line #634 was established. The donating investigator reports that these mice were backcrossed to C57BL/6J mice for at least 10 generations (see SNP note). Upon arrival at The Jackson Laboratory, mice were bred to C57BL/6J (Stock No. 000664) for at least one generation to establish the colony.
A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, 3 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a mixed C57BL/6J ; C57BL/6N genetic background.
|Expressed Gene||PyVT, Polyoma virus middle T antigen, polyoma virus|
|Site of Expression|
|Allele Name||transgene insertion 634, William Muller|
|Allele Type||Transgenic (Inserted expressed sequence)|
|Allele Synonym(s)||Tg(MMTV-PyVT)634Mul; transgene insertion 634, William Muller|
|Gene Symbol and Name||Tg(MMTV-PyVT)634Mul, transgene insertion 634, William Muller|
|Gene Synonym(s)||MTAG; Tg(MMTVPyVT)634Mul; TgN(MMTVPyVT)634Mul; PyMT; PyV-mT; PyVT; MMTV-PyMT; MMTV-PyVmT|
|Promoter||MMTV, Mouse Mammary Tumor Virus, MMTV|
|Expressed Gene||PyVT, Polyoma virus middle T antigen, polyoma virus|
|Strain of Origin||FVB/N|
|General Note||Additional lines produced include lines 121, 196, 235, 654, 668, 670.
These mice are used to study metastatic disease.
|Molecular Note||This transgene expresses polyoma virus middle T antigen under the control of the mouse mammary tumor virus LTR. Expression of this transgene was detected at high levels in male and female mammary glands. Other expression sites include salivary gland, seminal vesicles, ovaries, and lung.|
|Mutations Made By|| |
Dr. William Muller, McGill University
When maintaining a live colony, C57BL/6J inbred females (Stock No. 000664) may be bred with hemizygous males.
When using the MMTV-PyMT mouse strain in a publication, please cite the originating article(s) and include JAX stock #022974 in your Materials and Methods section.
|Hemizygous or Non carrier for Tg(MMTV-PyVT)634Mul/|
We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.